Cipla gains 9% on better-than-expected Q1 results

Cipla shares jumped about 9% in early trade on July 27 after the company's profits for the April-June period exceeded Street's estimates. Several brokerages raised their price estimates for the stock in response to the company's strong results for the quarter under review.

Because the company's bottom line and top line for the quarter exceeded analysts' expectations in Q1, management increased its margin goal for the current fiscal year to 23% from the previous aim of 22%.

Furthermore, management provided a solid growth outlook for the future quarters, projecting outperformance in the India prescription business and generating a quarterly run-rate of $210-215 million in US sales. All of the aforementioned benefits combined to create a favorable impression of Cipla.

Source: Media Reports

Related Blogs
blog-logo

Share Market

blog-logo

12 mins read . 12 Jul 2024

Ritesh Agarwal: The OYO Founder’s Success Story

  • 0 people read
blog-logo

Share Market

blog-logo

15 mins read . 08 Jul 2024

Best Oil & Gas Stocks in India

  • 0 people read
Kickstart your equities journey today You've got this
By submitting this I agree to the terms & conditions